Anika will receive product payment and royalty revenues from Medline’s sales of the product.
“The commercialization of Hyalomatrix by Medline in the United States is an important milestone achievement in our efforts to expand Anika’s advanced wound care product franchise,” said Anika president and CEO Charles Sherwood in a news release.
The agreement will run through 2019.
More articles on distribution agreements:
Medline to Partner with University of Rochester, Open Distribution Facility
Medline, Devon Medical Products Form Distribution Alliance
McKesson, Rite-Aid Expand Distribution Agreement
